I’ve been staying away from the board (other than to read

New Post Public Reply Private Reply Replies (2) Message Board
homerbedloe
377
I’ve been staying away from the board (other than to read highly recommended posts) because there just isn’t much to say positive or negative since in fact, we do not actually know what is going on behind the scenes – everyone here is speculating. But I’m getting a sense that people are expecting big things because of the back to back CC’s this week. That makes no sense to me at all at this point.

I have come to believe that nothing, and I mean NOTHING, is going to come out of the CCs that materially affects the pps. Joe could say it is now believed that AE37 cures cancer and the pps would not change. I think there are only two things that will affect pps for these two companies, and one probably won’t affect the other.

The NGIO spinout will create a value for NGIO shares. Hopefully, it will be in the multi-billion range, which will land NGIO at $5/share or above. This will happen, eventually, but nothing in the CC on Thurs will accelerate it. And for what it’s worth, I now believe that even this event will not affect GNBT’s share price. Yes, there will be a huge asset on GNBT’s books (maybe even something that can remove the going concern notice), but that does not mean it will translate to a pps rise. There may be a temporary bump, but it likely won’t be large and it won’t be long term. We saw this with the retirement of 20 million shares of GNBT – nadda, nyet, nothing happened with the pps. So why should an addition to the books make a difference?

What will make a difference? S1 funding? Nope – at least, not directly. Again, I believe there will a small bump in pps with the announcement of any of the S1 registrations, but it won’t last either. What will make a difference is once Joe gets funding, and he can further the subsidiaries to a point they start showing GROWING revenue, THEN we’ll see GNBT’s pps start a sustained upturn.
But that isn’t happening Wed, nor next month or probably throughout the 4th quarter this year. If we receive S1 approval in the next couple of months, I would expect at least another year before the funding can flow through to develop the businesses and start seeing actual revenues. So next year is the earliest I see GNBT’s pps doing anything, and even that might be optimistic.

Does this mean I think Joe isn’t doing all he can to increase value for shareholders? Nope – based on recent PRs, he has truly knitted a silk purse out of a sow’s ear. But it hasn’t and won’t matter - there is something going on behind the OTC scene that holds GNBT share price down. Bad actors, lack of interest or trust, market makers screwing around between themselves for whatever purposes? I don’t know, and it doesn’t make much difference if I did know because there’s nothing I or you can do about it. The news on GNBT has been such that it should rise, but it doesn’t. That is all that matters, and using that history, I’m projecting it to continue until Joe can fund the subsidiaries and they can establish their own worth.

NGIO will be different – it will trade on emotion (hope or fear) once it is uplisted. Sorry to those here that currently don’t have NGIO shares from the dividends; if you only have GNBT shares, you’ll have longer to wait for a payoff. I still think it will come, but it won’t be Wednesday, Thursday, next month or even early next year. If I’m right, you’ll have to make the decision do you want to keep holding for the turnaround, or are there better, more well thought of stocks (CYDY?) that you should be investing in.

My opinion only, mileage will vary.

Generex Biotechnology Corp. (GNBTQ) Stock Research Links

GNBTQ Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Trade Cases on Pizza Box Imports Set Industry Ablaze

Updated Category News Views 66

U.S. Takes Stand Against Unfair Import Practices Who knew pizza boxes could stir up such a fuss, huh? Well, here we are. The U.S. International Trade Commission (ITC) has sided with American pizza box manufacturers, waving the flag against those sneaky imports from China, Malaysia, and Turkey. According to the ITC, these imports are causing some real headaches for the...

Continue Reading
Duolingo Investors Must Weigh Legal Options Now

Updated Category News Views 101

Pressure Mounts on Duolingo Amid Legal Turmoil Well, here's a riddle solved with a lawsuit: when an app's growth hits the brakes, the lawyers seem to get moving fast. It seems like Duolingo, Inc. (NasdaqGS: DUOL) is learning a harsh lesson—not exactly in Spanish or French, but in the courtroom. They've been slapped with a securities class action, and it ain't looking...

Continue Reading
ScienceOra Unveils AI Catalyst Design at Tencent Summit

Updated Category News Views 54

AI in Material Science: Beyond Buzzwords There's a lot of talk out there about AI changing the world, but it's always a different tune when it's put under a microscope. At the 2026 Tencent Global Digital Ecosystem Summit, ScienceOra and Wenge AI showcased an AI-assisted workflow for designing hydrogen-production catalysts. This isn't your average AI cheerleading session,...

Continue Reading
Investigation of Maplebear Sale to DoorDash Sparks Debate

Updated Category News Views 174

Shareholders Fret Over Maplebear's Proposed Transaction It ain't every day a deal's got shareholders fidgeting more than a cat in a dog park, but here we are. Maplebear Inc. (NASDAQ: CART) finds itself under the magnifying glass as the seasoned crew over at Monteverde & Associates PC sound the alarm bells. The firm, sitting cozy in the Empire State Building, is on the...

Continue Reading
Aurora Innovation Faces Supply Chain Hurdles & Legal Scrutiny

Updated Category News Views 88

Aurora's Rough Road: Production Delays Unveiled You could almost hear the collective groan from investors when Aurora Innovation dropped the bombshell about its truck production delays. You know, after the cheery faces at the Q3 financial results reveal gave way to a rather grim reality check—driverless trucking ain't rolling out quite as planned thanks to those pesky...

Continue Reading
Orbis International to Boost Global Eye Health Efforts

Updated Category News Views 113

Pledge for Vision In a world where a staggering number of folks wrestle with avoidable vision issues, Orbis International is stepping up to the plate with ambitions that feel as bold as they are necessary. Orbis is pouring a significant $32 million into its mission to beef up eye health systems, train a small army of professionals, and apply AI in eye care. Their big bet...

Continue Reading
Twilio's SEC Investigation: Legal Impacts on Investors

Updated Category News Views 54

Twilio's Legal Troubles: Investors Take Notice Twilio's facing a firestorm, folks. After guiding its organic revenue growth down a few notches, the company saw its shares plummet 17%. Now, they're under the microscope for possibly not playing it straight with their growth numbers, and that’s never a good look with Uncle Sam watching. Folks at Levi & Korsinsky are on the...

Continue Reading
Neuberger Fund Ups Distribution Amid Market Challenges

Updated Category News Views 70

Neuberger Boosts Distribution: What's Driving This? I ain't about to sugarcoat it: the Neuberger Next Generation Connectivity Fund (NYSE: NBXG) decided to jack up its monthly distribution rate to $0.132 per share. This announcement, hitting wallets on November 30, 2026, has a record and ex-date of November 16. Now, that's a good ol' reliable payout for folks holding NBXG...

Continue Reading
Karma Automotive Debuts High-Stakes Eximius Program

Updated Category News Views 0

Breaking Ground with Bespoke Engineering Fancy seeing a car more unique than a snowflake, eh? Well, Karma Automotive is upending the luxury vehicle market with the launch of the Eximius program. Catering to the whims of the elite who aren’t just satisfied with a plethora of options, this is a game for those who crave a motorized extension of their ego and address book....

Continue Reading
WesternU's Big Night: Boosting Lebanon’s Health Hub

Updated Category News Views 64

Building Bridges in Healthcare: WesternU's Strategic Move Heck, you know it's the real deal when a university throws a dinner party to celebrate partnerships. Western University of Health Sciences (WesternU) decided to clink glasses with Lebanon community leaders, hammering home the importance of their collaboration on October 6, 2026. Now, don't think this was just some...

Continue Reading

Top 5 Most Recently Viewed Articles

America's Car-Mart Faces Scrutiny Over Financial Disclosures

Updated Category News Views 384

America's Car-Mart Under Investor Scrutiny Recently, America's Car-Mart, Inc. (NASDAQ: CRMT) experienced a noteworthy stock decline as investors reacted to disappointing Q1 2026 financial results. The significant drop of over $8, approximately 18%, raised concerns among shareholders and prompted investigation into the company's operational strategies concerning tariff...

Continue Reading
Lands' End Reports Positive Financial Growth for Fiscal Year 2024

Updated Category News Views 210

Lands' End Achieves Significant Financial Milestones DODGEVILLE, Wis. – Lands’ End, Inc. (NASDAQ: LE) has announced its financial results for the fourth quarter and the entire fiscal year 2024, which concluded recently. This announcement follows a year characterized by steady growth and strategic innovation. Strong Performance in the Fourth Quarter During the fourth...

Continue Reading
Novo Nordisk's Wegovy® Shows Promise for Liver Health in MASH

Updated Category News Views 217

Wegovy® Demonstrates Hepatic Benefits Beyond Weight Loss Novo Nordisk has recently unveiled intriguing findings regarding Wegovy® (semaglutide 2.4 mg) that highlight its role in enhancing liver health in adults diagnosed with metabolic dysfunction-associated steatohepatitis (MASH), even in the context of limited weight loss. This revelation emerged from a post hoc...

Continue Reading
Free Software Revolutionizing Sustainability in Real Estate

Updated Category News Views 92

Measurabl Introduces Free Sustainability Software Measurabl, renowned for its sustainability data platform in real estate, has unveiled a groundbreaking free software solution. This innovative tool allows property and portfolio managers to measure, manage, and report on sustainability performance without any cost. With this recent launch, Measurabl has already registered...

Continue Reading
The Joint Corp. Achieves Significant Growth in 2024 Metrics

Updated Category News Views 138

The Joint Corp. Showcases Remarkable Growth in 2024 Metrics - Adjustments Performed in 2024 Grows 9%, Compared to 2023 - - Receives Letters of Intent for Majority of Corporate Portfolio - SCOTTSDALE, Ariz. — The Joint Corp. (NASDAQ: JYNT), a leader in chiropractic care across the nation, has reported impressive operating metrics for the year ending 2024. The company's...

Continue Reading